Cargando…

A case of rapidly progressive IgA nephropathy in a patient with exacerbation of Crohn’s disease

BACKGROUND: IgA nephropathy has been reported as a renal involvement in Crohn’s disease. Crescentic IgA nephropathy, which accounts for fewer than 5% of cases of IgA nephropathy, has a poorer prognosis than other forms of crescentic glomerulonephritis. We recently experienced a case of rapidly progr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Ji-Young, Yu, Chung Hoon, Jung, Hee-Yeon, Jung, Min Kyu, Kim, Yong-Jin, Cho, Jang-Hee, Kim, Chan-Duck, Kim, Yong-Lim, Park, Sun-Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724487/ https://www.ncbi.nlm.nih.gov/pubmed/22866754 http://dx.doi.org/10.1186/1471-2369-13-84

Ejemplares similares

Impact of gene polymorphisms of interleukin-18, transforming growth factor-β, and vascular endothelial growth factor on development of IgA nephropathy and thin glomerular basement membrane disease
por: Jung, Hee-Yeon, et al.
Publicado: (2012)

IgA nephropathy associated with Crohn's disease
por: Tamura, Hiroshi
Publicado: (2023)

Beta-Thalassemia Minor Is Associated with IgA Nephropathy
por: Kang, Jung Hyun, et al.
Publicado: (2013)

Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change Disease
por: Cho, Won-Hee, et al.
Publicado: (2020)

Exacerbation of IgA nephropathy in a patient receiving dupilumab
por: Yamamoto, Masako, et al.
Publicado: (2022)

The Mildly Elevated Serum Bilirubin Level is Negatively Associated with the Incidence of End Stage Renal Disease in Patients with IgA Nephropathy
por: Chin, Ho Jun, et al.
Publicado: (2009)

Treatment of rituximab in patients with idiopathic membranous nephropathy: a case series and literature review
por: Jeon, Soo-Jee, et al.
Publicado: (2022)

Exceptional mucocutaneous manifestations with amyloid nephropathy: a case report
por: Yoon, Se-Hee, et al.
Publicado: (2018)

Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy
por: Song, Eun Joo, et al.
Publicado: (2018)

Remission of Proteinuria May Protect against Progression to Chronic Kidney Disease in Pediatric-Onset IgA Nephropathy
por: Suh, Jin-Soon, et al.
Publicado: (2020)

ACE Gene Polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients
por: Han, Sang Youb, et al.
Publicado: (2000)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

The possible involvement of intestine-derived IgA(1): a case of IgA nephropathy associated with Crohn’s disease
por: Terasaka, Tomohiro, et al.
Publicado: (2016)

Idiopathic membranous nephropathy in older patients: Clinical features and outcomes
por: Choi, Ji-Young, et al.
Publicado: (2020)

IgA nephropathy is associated with elevated urinary mitochondrial DNA copy numbers
por: Yu, Byung Chul, et al.
Publicado: (2019)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Comprehensive metabolomic profiling in early IgA nephropathy patients reveals urine glycine as a prognostic biomarker
por: Park, Sehoon, et al.
Publicado: (2021)

Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy
por: Kim, Yong-Chul, et al.
Publicado: (2013)

Hypertriglyceridemia Is Associated with More Severe Histological Glomerulosclerosis in IgA Nephropathy
por: Choi, Won Jung, et al.
Publicado: (2021)

Long-term prognosis of clinically early IgA nephropathy is not always favorable
por: Lee, Hajeong, et al.
Publicado: (2014)

Genome-wide association study identifies new susceptible loci of IgA nephropathy in Koreans
por: Jeong, Kyung Hwan, et al.
Publicado: (2019)

Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy [Volume 37, Issue 3, September 2018, Pages 248–256]
por: Song, Eun Joo, et al.
Publicado: (2018)

Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study
por: Oh, Yun Jung, et al.
Publicado: (2015)

The Impact of Obesity on the Severity of Clinicopathologic Parameters in Patients with IgA Nephropathy
por: Hong, Yu Ah, et al.
Publicado: (2020)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Jin Sug, et al.
Publicado: (2020)

Smoking-Related Renal Histologic Injury in IgA Nephropathy Patients
por: Cha, Yoon Jin, et al.
Publicado: (2016)

Comparative analysis of the tonsillar microbiota in IgA nephropathy and other glomerular diseases
por: Park, Ji In, et al.
Publicado: (2020)

Immunological abnormalities in patient with IgA nephropathy.
por: Ihm, C. G., et al.
Publicado: (1986)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Disruption of Smad4 Expression in T Cells Leads to IgA Nephropathy-Like Manifestations
por: Inoshita, Hiroyuki, et al.
Publicado: (2013)

The Emerging Role of Pathogenesis of IgA Nephropathy
por: Wu, Meng-Yu, et al.
Publicado: (2018)

The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial
por: Choi, Ji-Young, et al.
Publicado: (2018)

Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study
por: Park, Sehoon, et al.
Publicado: (2019)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vnfej6tcq2pqtdsbqa02megtht